Gerard Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, shared perspective with Clinical Trials Arena for an article highlighting four biologics being investigated in COPD that are coming to the end of Phase III trials.